Novitium Pharma is now part of ANI Pharmaceuticals. READ MORE >

About Us

Locations

Corporate Headquarters
(Baudette, Minnesota)

210 Main Street West
Baudette, MN 56623
Phone: 218-634-3500
Fax: 218-634-3540


Overview
  • 130,000 square feet Corporate Headquarters
  • 57,000 square feet of manufacturing, packaging, and warehouse
  • Recently completed 5,500 square feet warehouse expansion includes additional schedule CII vault & CIII cage space
  • 17,000 square feet of laboratory space for product development and analytical testing
  • 56,000 square feet of employee, office and mechanical space
Capabilities
  • Rx solutions, suspensions, topicals, tablets, capsules, and powder for suspension
  • DEA-licensed for Schedule II controlled substances
Capacity
  • Solid Dose ~1.2 billion doses/yr
  • Liquids ~53 million bottles/yr
  • Liquid Unit Dose ~23 million doses/yr
  • Powder ~12 million bottles/yr
Containment Facility
(Baudette, Minnesota)

455 IDC Road
Baudette, MN 56623
Phone: 218-634-3500
Fax: 218-634-3540


Overview
  • 47,000 square feet Containment Facility
  • 32,000 square feet of manufacturing, packaging, and warehouse
  • 100 nano-gram per eight-hour time weighted average maximum exposure limit to ensure employee safety
  • Low-humidity suite for processing and encapsulating moisture-sensitive compounds
  • 15,000 square feet of employee, office and mechanical space
Capabilities
  • Fully-contained high potency facility with capabilities to manufacture hormone, steroid, and oncolytic products
  • DEA Schedule III capability
Capacity
  • Tablets ~2.5 billion doses/yr
  • Capsules ~150 million doses/yr
  • Liquids ~3 million bottles/yr
  • Topicals ~2 million tubes/yr
Oakville Facility
(Ontario, Canada)

400 Iroquois Shore Road
Oakville, ON L6H 1M5
Phone: 905-337-4500
Fax: 905-337-3539


Overview
  • 101,000 square feet of manufacturing, packaging, lab, warehouse, and administrative space
  • US FDA and Health Canada inspected
  • Controlled drugs and substance license
Capabilities
  • Rx solutions, suspensions, topicals, tablets, and capsules
  • Serialization-ready
Capacity
  • Tablets ~1 billion doses/yr
  • Capsules ~340 million doses/yr
  • Liquids ~3 million bottles/yr
  • Topicals ~2 million tubes/yr